Investigators described a strategy that utilizes pretargeting and glycochemistry to bioengineer β cells in situ to induce β-cell-specific tolerance.
[ACS Nano]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.